EDOLME Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for EDOLME with the United States Patent and Trademark Office. The USPTO has given the EDOLME trademark a serial number of 86450961. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 8, 2024. This trademark is owned by Glaxo Group Limited. The EDOLME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
edolme

General Information

Serial Number86450961
Word MarkEDOLME
Filing DateTuesday, November 11, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 8, 2024
Registration Number5268668
Registration DateTuesday, August 22, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, March 8, 2024CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 22, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 22, 2017REGISTERED-PRINCIPAL REGISTER
Friday, July 14, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, June 13, 2017NOTICE OF ALLOWANCE CANCELLED
Tuesday, June 13, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016SOU EXTENSION 3 GRANTED
Thursday, December 1, 2016SOU EXTENSION 3 FILED
Thursday, December 1, 2016SOU TEAS EXTENSION RECEIVED
Saturday, July 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 1, 2016SOU EXTENSION 2 GRANTED
Tuesday, May 31, 2016SOU EXTENSION 2 FILED
Friday, July 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Friday, November 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 18, 2015SOU EXTENSION 1 GRANTED
Wednesday, November 18, 2015SOU EXTENSION 1 FILED
Wednesday, November 18, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2015ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 13, 2015ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, March 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 14, 2014NEW APPLICATION ENTERED

Related Keywords

edolme pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological